Podcast appearances and mentions of jessica ailani

Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.

Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade. Disclosures can be found at Neurology.org. 

Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.  Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200359 

Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.  Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Dr. Jessica Ailani and Dr. Francesca Puledda discuss the International Headache Society's global practice recommendations for acute and preventive treatment of migraine. Show reference:  https://journals.sagepub.com/doi/10.1177/03331024241252666  https://journals.sagepub.com/doi/full/10.1177/03331024241269735  

Carrie Dougherty, MD, FAHS and Jessica Ailani, MD review migraine abstracts from the 2024 European Headache Congress.

Jessica Ailani, MD and Carrie Dougherty, MD, FAHS debate initial preventive treatment for migraine and the in-clinic management of status migraine.

Dr. Jessica Ailani talks with Dr. Francesca Puledda about the International Headache Society's global practice recommendations for the acute and preventive treatment of migraine. Read the related recommendations for the acute pharmacological treatment of migraine in Sage Journals. Read the related recommendations for pharmacological treatment of migraine in Sage Journals. Disclosures can be found at Neurology.org.

Join Wade Cooper, DO and Jessica Ailani, MD as they share highlights from the 2024 American Academy of Neurology (AAN) annual meeting in Denver, Colorado. In this first episode of a three‑part series, they discuss acute medication overuse in people with migraine, strategies to help patients to avoid overuse, and layering migraine therapies, among other topics.

Dr. Jessica Ailani and Dr. Ian Carroll discuss intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209449  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jessica Ailani talks with Dr. Ian Carroll about intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

Drs. Jessica Ailani and Willebrordus Petrus Johannes Van Oosterhout discuss the occurrence, characteristics, and evolution of space headaches during long-duration flights. Show Reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000209224  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jessica Ailani talks with Dr. Willebrordus Petrus Johannes Van Oosterhout about the occurrence, characteristics, and evolution of space headaches during long-duration flights. Read the related article in Neurology.  Disclosures can be found at Neurology.org.

CME credits: 0.25 Valid until: 13-02-2025 Claim your CME credit at https://reachmd.com/programs/cme/patient-centric-approaches-to-managing-migraines-in-the-female-patient/16281/ Half of the women in the US with migraine are never diagnosed. Of those who are, the journey to effective treatment may last a decade or longer. But newer and more effective targeted treatments are beginning to make a difference. Join Drs. Jessica Ailani and Dawn Buse as they discuss a novel approach to managing migraine and interview a patient whose migraine journey is unfortunately one traversed by many women.=

CME credits: 0.25 Valid until: 13-02-2025 Claim your CME credit at https://reachmd.com/programs/cme/migraine-clinical-approaches-and-a-patients-perspective/16281/ Half of the women in the US with migraine are never diagnosed. Of those who are, the journey to effective treatment may last a decade or longer. But newer and more effective targeted treatments are beginning to make a difference. Join Drs. Jessica Ailani and Dawn Buse as they discuss a novel approach to managing migraine and interview a patient whose migraine journey is unfortunately one traversed by many women.=

Dr. Jessica Ailani discusses her favorite clinical pearls in regards to headache medicine. Show references: Red and orange flags for secondary headaches in clinical practice SNNOOP10 list Green Flags and Headache: A Concept Study Using the Delphi Method

CME credits: 0.75 Valid until: 05-12-2024 Claim your CME credit at https://reachmd.com/programs/cme/migraine-and-womens-health-migraine-and-the-whole-female-patient/15904/ Upwards of 47 million people in the U.S. suffer from migraines, often accompanied by widespread personal, professional, and social disabilities. Though a similar prevalence is initially observed between men and women, by mid-adulthood the prevalence of migraine is 3-fold greater in women than men. Newer agents, both injectable and oral and focused on modulating the calcitonin gene-related peptide pathway, have emerged and have proven highly effective in managing both acute and chronic migraine. Join Drs. Jessica Ailani and Dawn Buse as they provide an overview of the changing landscape of migraine therapy, especially as it impacts women across different life-stages.=

Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraine.  Read the related article in Neurology. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Go online to PeerView.com/MWU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, Dr. Jessica Ailani reviews the latest data on therapies for acute and preventive management of migraine, with a focus on personalized treatment. A patient interview and 3D animation are also part of this engaging video program. Upon completion of this activity, participants should be better able to: Apply safety and efficacy data related to new acute migraine therapies in clinical decision-making, taking into account patient-reported outcomes; Employ evidence-based prevention strategies for patients with migraine; and Implement individualized treatment plans for patients with migraine.

Go online to PeerView.com/MWU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, Dr. Jessica Ailani reviews the latest data on therapies for acute and preventive management of migraine, with a focus on personalized treatment. A patient interview and 3D animation are also part of this engaging video program. Upon completion of this activity, participants should be better able to: Apply safety and efficacy data related to new acute migraine therapies in clinical decision-making, taking into account patient-reported outcomes; Employ evidence-based prevention strategies for patients with migraine; and Implement individualized treatment plans for patients with migraine.

Go online to PeerView.com/MWU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, Dr. Jessica Ailani reviews the latest data on therapies for acute and preventive management of migraine, with a focus on personalized treatment. A patient interview and 3D animation are also part of this engaging video program. Upon completion of this activity, participants should be better able to: Apply safety and efficacy data related to new acute migraine therapies in clinical decision-making, taking into account patient-reported outcomes; Employ evidence-based prevention strategies for patients with migraine; and Implement individualized treatment plans for patients with migraine.

Go online to PeerView.com/MWU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, Dr. Jessica Ailani reviews the latest data on therapies for acute and preventive management of migraine, with a focus on personalized treatment. A patient interview and 3D animation are also part of this engaging video program. Upon completion of this activity, participants should be better able to: Apply safety and efficacy data related to new acute migraine therapies in clinical decision-making, taking into account patient-reported outcomes; Employ evidence-based prevention strategies for patients with migraine; and Implement individualized treatment plans for patients with migraine.

Go online to PeerView.com/MWU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, Dr. Jessica Ailani reviews the latest data on therapies for acute and preventive management of migraine, with a focus on personalized treatment. A patient interview and 3D animation are also part of this engaging video program. Upon completion of this activity, participants should be better able to: Apply safety and efficacy data related to new acute migraine therapies in clinical decision-making, taking into account patient-reported outcomes; Employ evidence-based prevention strategies for patients with migraine; and Implement individualized treatment plans for patients with migraine.

Go online to PeerView.com/MWU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, Dr. Jessica Ailani reviews the latest data on therapies for acute and preventive management of migraine, with a focus on personalized treatment. A patient interview and 3D animation are also part of this engaging video program. Upon completion of this activity, participants should be better able to: Apply safety and efficacy data related to new acute migraine therapies in clinical decision-making, taking into account patient-reported outcomes; Employ evidence-based prevention strategies for patients with migraine; and Implement individualized treatment plans for patients with migraine.

The April 2023 replay of past episodes showcases our November 2022 headache series hosted by Dr. Tesha Monteith. The first episode features a conversation with Dr. Peter Goadsby about value offered by headache classifications, followed by and interview with Drs. Simona Sacco and Jessica Ailani about an update on migraine guidelines. Next in the episode, Dr. Lars Edvinsson discusses CGRP and role of sex hormones. The April recall closes out with an interview with Dr. Rebecca Burch about hot topics in headache medicine.  

Dr. Jessica Ailani talks with Dr. Katharina Wolf, about MRI of CSF-flow and spinal cord motion being a promising diagnostic tool in SIH. Read the full article in Neurology.

Dr. Jessica Ailani discusses current migraine guidelines. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

This activity expires on MONDAY, DECEMBER 5! In this podcast episode from i3 Health, expert faculty provide insight on new data and emerging strategies for patients with migraine headaches including prevention, treatment, and strategies for management related to adverse events and supportive care. Presented by Jessica Ailani, MD, Director, MedStar Georgetown Headache Center, MedStar Georgetown University Hospital, and Calli Cook, DNP, APRN, FNP-C, FAANP, Clinical Assistant Professor, Nell Hodgson Woodruff School of Nursing, Emory University. Listen now! Click here to claim CME/NCPD/CPE credit: https://i3health.com/podcast-migraine

Dr. Tesha Monteith talks with Dr. Simona Sacco and Dr. Jessica Ailani about migraine guidelines as part of the November Headache Series. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with the chairs of the recently hosted International Congress on the Future of Neurology (IFN), including Stephen Krieger, MD, professor of neurology and neurologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai; Richard Isaacson, MD, director of the Center for Brain Health at the Florida Atlantic University Schmidt College of Medicine; and Jessica Ailani, MD, associate professor of neurology and director of the MedStar Georgetown Headache Center. They joined the show to recap their experience at the 2022 IFN meeting, discuss the value of cross-specialty interactions, share their perspective on the future of their fields, and more. To learn more about the Congress and other Physician's Education Resource CME activities, visit gotoper.com. Episode Breakdown: 1:15 – Richard Isaacson, MD, on his experience 3:20 – Stephen Krieger, MD, on his experience 6:20 – Jessica Ailani, MD, on her experience 9:45 – Krieger on the benefits of cross-specialty interactions 11:25 – Isaacson on the concept of earlier identification of disease 14:25 – Ailani on increasing diversity and discussion across neurology 16:00 – Krieger on the takeaways from COVID-19 in multiple sclerosis 18:55 – Ailani on the challenges of comorbidity and telemedicine 20:55 – Isaacson on the need to focus on the future of neurology This episode is brought to you by the Medical World News streaming service. Check out new content and shows every day, only at medicalworldnews.com Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Dr. Jessica Ailani talks with Dr. Susan Mollan about the amount of weight loss required to reduce intracranial pressure in patients with idiopathic intracranial hypertension. Show references: Read the full article here: https://n.neurology.org/content/99/11/e1090 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jessica Ailani talks with Dr. Susan Mollan about the amount of weight loss required to reduce intracranial pressure in patients with idiopathic intracranial hypertension. Read the full article in Neurology. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Please visit answersincme.com/AFP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the most up-to-date recommendations and clinical evidence on oral calcitonin gene-related peptide (CGRP)–targeted therapies for the acute and preventive management of migraine disease. Upon completion of this activity, participants should be better able to: Review the latest American Headache Society consensus statement recommendations for the treatment of migraine disease; Describe the latest clinical evidence on approved oral CGRP-targeted therapies in the management of migraine disease; and Outline practical, patient-centered strategies to optimize the use of oral CGRP-targeted therapies in the management of migraine disease.

Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Jessica Ailani, MD, director, MedStar Georgetown Headache Center, and associate professor of neurology, MedStar Georgetown University Hospital. She spoke about some recent data in headache medicine that has provided evidence of the in-clinic experience and how the migraine treatment landscape has shifted, and what challenges need to be addressed to achieve the goal of developing personalized treatment regimens for patients. Episode Breakdown: 1:25 – Migraine highlights from the 2022 AAN Annual Meeting. 5:00 – Atogepant post hoc analyses showing dose-dependent weight loss. 9:25 – Rimegepant data and optimizing available treatments for quality of life. 12:50 – Current day-to-day challenges in migraine care. 15:10 – Neurology News Minute 18:50 – Progress made toward increasing migraine training and education. 22:45 – Other specialty's understanding of the migraine population. 27:35 – The importance of behavioral interventions in migraine. 32:05 – Looking ahead to the future of care. The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Axsome Issued CRL for AXS-07 in Acute Migraine Treatment FDA Approves Ravulizumab for Adults With Generalized Myasthenia Gravis FDA Permits Marketing for Plaque-Detecting Diagnostic Test for Alzheimer Disease Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this podcast episode from i3 Health, expert faculty provide insight on new data and emerging strategies for patients with migraine headaches including prevention, treatment, and strategies for management related to adverse events and supportive care. Presented by Jessica Ailani, MD, Director, MedStar Georgetown Headache Center, MedStar Georgetown University Hospital, and Calli Cook, DNP, APRN, FNP-C, FAANP, Clinical Assistant Professor, Nell Hodgson Woodruff School of Nursing, Emory University. Listen now!

In part 3 of a 3 part series, Jessica Ailani, MD, FAHS, FAAN, discusses her article, “Acute Migraine Treatment" from the June Headache Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/AcuteMig.

In part 2 of a 3 part series, Jessica Ailani, MD, FAHS, FAAN, discusses her article, “Acute Migraine Treatment" from the June Headache Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/AcuteMig.

In part 1 of a 3 part series, Jessica Ailani, MD, FAHS, FAAN, discusses her article, “Acute Migraine Treatment" from the June Headache Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/AcuteMig.